The following post comes from Terence Yen, a 4E at Scalia Law and a Research Assistant at CPIP. By Terence Yen In his new paper, Patent Eligibility and Investment, Professor […]
[Archived Post] Rethinking § 101: Professor Talha Syed Takes a Different Look at Subject Matter Eligibility
The following post comes from Colin Kreutzer, a 2E at Scalia Law and a Research Assistant at CPIP. By Colin Kreutzer When most people think of patentability requirements, they think […]
[Archived Post] “No Combination Drug Patents Act” Stalls, but Threats to Innovation Remain
By Kevin Madigan & Sean O’Connor This week, the Senate Judiciary Committee was to mark up a bill limiting patent eligibility for combination drug patents—new forms, uses, and administrations of […]
[Archived Post] CPIP Scholars To Federal Circuit: Protect Innovation in the Life Sciences
Last week, a group of CPIP scholars—Chris Holman, David Lund, Adam Mossoff, and Kristen Osenga—filed an amicus brief in Natural Alternatives International v. Creative Compounds, a case currently on appeal […]
[Archived Post] CPIP Scholars File Amicus Brief in Trading Technologies v. CQG
By Bhamati Viswanathan Earlier this month, CPIP Senior Scholar Adam Mossoff penned an amicus brief in Trading Technologies v. CQG, currently on appeal to the Federal Circuit. The brief was […]
[Archived Post] Federal Circuit Brings Some Clarity and Sanity Back to Patent Eligibility Doctrine
By Adam Mossoff and Kevin Madigan Following the Supreme Court’s four decisions on patent eligibility for inventions under § 101 of the Patent Act, there has been much disruption and […]
[Archived Post] #AliceStorm: When It Rains, It Pours…
The following guest post from Robert R. Sachs, Partner at Fenwick & West LLP, first appeared on the Bilski Blog, and it is reposted here with permission. By Robert R. […]
[Archived Post] #AliceStorm for Halloween: Was it a Trick or a Treat?
The following guest post from Robert R. Sachs, Partner at Fenwick & West LLP, first appeared on the Bilski Blog, and it is reposted here with permission. By Robert R. […]
[Archived Post] Overview of Comments on the USPTO’s July 2015 Update to the Interim Examination Guidance
The following guest post from Robert R. Sachs, Partner at Fenwick & West LLP, first appeared on the Bilski Blog, and it is reposted here with permission. By Robert R. […]
[Archived Post] Federal Circuit Should Reconsider Ariosa v. Sequenom: The Panel Decision Threatens Modern Innovation
Here’s a brief excerpt of a post by Devlin Hartline that was published on IPWatchdog. In an amicus brief co-authored by Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP […]